<DOC>
	<DOCNO>NCT00412035</DOCNO>
	<brief_summary>The purpose six site multi-center study determine BTX-A alleviate post-operative pain improve functional quality life outcomes child limb length discrepancy angular deformity undergo limb lengthen deformity correction .</brief_summary>
	<brief_title>Botox Injection Lower Extremity Lengthening Deformity Correction Surgery</brief_title>
	<detailed_description>The specific aim determine BTX-A : - 1a . Reduce pain post operatively distraction consolidation process , - 1b . Reduce amount , frequency duration narcotic take postoperative period . - 2 . Improve quality life distraction consolidation process . - 3 Decrease muscular spasm subsequent muscle contracture distraction consolidation process accelerate earlier return pre-operative mobility function include early weight bearing . - 4 . To develop clinical practice guideline interdisciplinary care child undergo limb lengthen deformity correction . Methodology : A randomization process one time injection use determine receive BTX-A placebo . 150 subject recruit ; 75 BTX-A group 75 placebo group . There equal number subject group site . The medication inject intraoperatively specific major muscle low limb adjacent bone soft tissue lengthen correct dose 10 U/kg maximum 50 U per site , exceed total maximum dose 400 unit . Pain score , medication dosage , range motion ambulation scale measure post-operatively distraction consolidation phase . In addition family ask complete six different questionnaire relate pain , quality life psycho-social issue various time process . The child receive standard nursing care physical therapy follow three month external fixator remove , total time approximately one year .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Lower Extremity Deformities , Congenital</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Age : 5 21 year . Aetiology deformity : congenital acquire . Amount lengthen deformity correction : amount . Site lengthen deformity correction : low extremity . Type fixator : circular uniplanar . Children young 5 year age . Associated neuromuscular condition may hinder weight bearing . Individuals aminoglycosides , aminoglycosides potentiate effect Botulinum toxin A .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>